Rel/NF‐κB can trigger the Notch signaling pathway by inducing the expression of Jagged1, a ligand for Notch receptors

Jagged1 belongs to the DSL family of ligands for Notch receptors that control the proliferation and differentiation of various cell lineages. However, little is known about the transcription factors that regulate its expression. Here, we show that Jagged1 is a Rel/NF‐κB‐responsive gene. Both c‐Rel and RelA induced jagged1 gene expression, whereas a mutant defective for transactivation did not. Importantly, jagged1 transcripts were also upregulated by endogenous NF‐κB activation and this effect was inhibited by a dominant mutant of IκBα, a physiological inhibitor of NF‐κB. Cell surface expression of Jagged1 in c‐Rel‐expressing cell monolayers led to a functional interaction with lymphocytes expressing the Notch1/TAN‐1 receptor. This correlated with the initiation of signaling downstream of Notch, as evidenced by increased levels of HES‐1 transcripts in co‐cultivated T cells and of CD23 transcripts in co‐cultivated B cells. Consistent with its Rel/NF‐κB‐dependent induction, Jagged1 was found to be highly expressed in splenic B cells where c‐Rel is expressed constitutively. These results demonstrate that c‐Rel can trigger the Notch signaling pathway in neighboring cells by inducing jagged1 gene expression, and suggest a role for Jagged1 in B‐cell activation, differentiation or function. These findings also highlight the potential for an interplay between the Notch and NF‐κB signaling pathways in the immune system.

[1]  H. Kikutani,et al.  Epstein-Barr Virus Nuclear Protein 2 Transactivates a cis-Acting CD 23 DNA Element , 2022 .

[2]  Y. Jan,et al.  Roles for Proteolysis and Trafficking in Notch Maturation and Signal Transduction , 1998, Cell.

[3]  H. Kim,et al.  The Notch Pathway Intermediate HES-1 Silences CD4 Gene Expression , 1998, Molecular and Cellular Biology.

[4]  M. Malim,et al.  Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-kappaB control. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[5]  G. Krämmer,et al.  Construction of a fusion gene that confers resistance against hygromycin B to mammalian cells in culture. , 1985, Experimental cell research.

[6]  S. Ghosh,et al.  Rel/NF-?B and I?B proteins: an overview , 1997 .

[7]  A. Baldwin,et al.  THE NF-κB AND IκB PROTEINS: New Discoveries and Insights , 1996 .

[8]  M. Karin,et al.  Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. , 1997, The New England journal of medicine.

[9]  G. Weinmaster,et al.  An Activated Form of Notch Influences the Choice between CD4 and CD8 T Cell Lineages , 1996, Cell.

[10]  J. Sklar,et al.  Functional analysis of the TAN-1 gene, a human homolog of Drosophila notch. , 1994, Cold Spring Harbor symposia on quantitative biology.

[11]  J Vandekerckhove,et al.  Inhibition of the DNA-binding activity of Drosophila suppressor of hairless and of its human homolog, KBF2/RBP-J kappa, by direct protein-protein interaction with Drosophila hairless. , 1994, Genes & development.

[12]  S. Bray A Notch Affair , 1998, Cell.

[13]  A. Israël,et al.  Delta-1 Activation of Notch-1 Signaling Results inHES-1 Transactivation , 1998, Molecular and Cellular Biology.

[14]  M. Gossen,et al.  Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[15]  C. Larsson,et al.  The human NOTCH1, 2, and 3 genes are located at chromosome positions 9q34, 1p13-p11, and 19p13.2-p13.1 in regions of neoplasia-associated translocation. , 1994, Genomics.

[16]  J. Posakony,et al.  Suppressor of hairless directly activates transcription of enhancer of split complex genes in response to Notch receptor activity. , 1995, Genes & development.

[17]  I. Bernstein,et al.  The Notch ligand, Jagged-1, influences the development of primitive hematopoietic precursor cells. , 1998, Blood.

[18]  J. Hsieh,et al.  Epstein-Barr virus immortalization: Notch2 interacts with CBF1 and blocks differentiation , 1997, Journal of virology.

[19]  B. Fowlkes,et al.  Notch Activity Influences the αβ versus γδ T Cell Lineage Decision , 1997, Cell.

[20]  W. Zong,et al.  Rel blocks both anti-Fas- and TNFα-induced apoptosis and an intact Rel transactivation domain is essential for this effect , 1998, Cell Death and Differentiation.

[21]  A. Bigas,et al.  Notch1 and Notch2 Inhibit Myeloid Differentiation in Response to Different Cytokines , 1998, Molecular and Cellular Biology.

[22]  R. Shigemoto,et al.  Two mammalian helix-loop-helix factors structurally related to Drosophila hairy and Enhancer of split. , 1992, Genes & development.

[23]  Céline Gélinas,et al.  Rel/NF-?B and I?B factors in oncogenesis , 1997 .

[24]  C. Gélinas,et al.  I kappa B alpha-mediated inhibition of v-Rel DNA binding requires direct interaction with the RXXRXRXXC Rel/kappa B DNA-binding motif. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[25]  E. Kieff,et al.  Epstein-Barr virus nuclear protein 2 transactivates a cis-acting CD23 DNA element , 1991, Journal of virology.

[26]  M. Boothby,et al.  Perturbation of the T Lymphocyte Lineage In Transgenic Mice Expressing a Constitutive Repressor of Nuclear Factor (NF)-κB , 1997, The Journal of experimental medicine.

[27]  T. Honjo,et al.  The recombination signal sequence-binding protein RBP-2N functions as a transcriptional repressor , 1994, Molecular and cellular biology.

[28]  B. Trask,et al.  The human homolog of rat Jagged1 expressed by marrow stroma inhibits differentiation of 32D cells through interaction with Notch1. , 1998, Immunity.

[29]  E. Kopp,et al.  NF-kappa B and rel proteins in innate immunity. , 1995, Advances in immunology.

[30]  G. Weinmaster,et al.  The Ins and Outs of Notch Signaling , 1997, Molecular and Cellular Neuroscience.

[31]  H. Okayama,et al.  High-efficiency transformation of mammalian cells by plasmid DNA. , 1987, Molecular and cellular biology.

[32]  Raphael Kopan,et al.  Notch-1 signalling requires ligand-induced proteolytic release of intracellular domain , 1998, Nature.

[33]  C. Scheidereit,et al.  The NF-κB/Rel and IκB gene families: mediators of immune response and inflammation , 1996, Journal of Molecular Medicine.

[34]  R. Warnke,et al.  Clinical and biologic characterization of T-cell neoplasias with rearrangements of chromosome 7 band q34. , 1988, Blood.

[35]  I. Bernstein,et al.  A human homologue of the Drosophila developmental gene, Notch, is expressed in CD34+ hematopoietic precursors. , 1994, Blood.

[36]  J. Rossant,et al.  Conservation of the Notch signalling pathway in mammalian neurogenesis. , 1997, Development.

[37]  A. Pardee,et al.  Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. , 1992, Science.

[38]  J. Sklar,et al.  Exclusive development of T cell neoplasms in mice transplanted with bone marrow expressing activated Notch alleles , 1996, The Journal of experimental medicine.

[39]  J. Banchereau,et al.  Stable transfection of Epstein-Barr virus (EBV) nuclear antigen 2 in lymphoma cells containing the EBV P3HR1 genome induces expression of B-cell activation molecules CD21 and CD23 , 1990, Journal of virology.

[40]  C Gélinas,et al.  c-Rel arrests the proliferation of HeLa cells and affects critical regulators of the G1/S-phase transition , 1997, Molecular and cellular biology.

[41]  E. Robey Notch in vertebrates. , 1997, Current opinion in genetics & development.

[42]  Colin C. Collins,et al.  Alagille syndrome is caused by mutations in human Jagged1, which encodes a ligand for Notch1 , 1997, Nature Genetics.

[43]  E. Kieff,et al.  Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[44]  J. Boulter,et al.  Jagged: A mammalian ligand that activates notch1 , 1995, Cell.

[45]  S. Minoguchi,et al.  Physical interaction between a novel domain of the receptor Notch and the transcription factor RBP-Jκ/Su(H) , 1995, Current Biology.

[46]  M. Fortini,et al.  The suppressor of hairless protein participates in notch receptor signaling , 1994, Cell.

[47]  H. Weintraub,et al.  Signal transduction by activated mNotch: importance of proteolytic processing and its regulation by the extracellular domain. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[48]  D. Carrasco,et al.  Developmental expression of the mouse c-rel proto-oncogene in hematopoietic organs. , 1994, Development.

[49]  F. Schweisguth,et al.  The neurogenic suppressor of hairless DNA-binding protein mediates the transcriptional activation of the enhancer of split complex genes triggered by Notch signaling. , 1995, Genes & development.

[50]  A. Israël,et al.  IκB proteins: structure, function and regulation , 1997 .

[51]  J. Hsieh,et al.  EBNA-2 upregulation of Epstein-Barr virus latency promoters and the cellular CD23 promoter utilizes a common targeting intermediate, CBF1 , 1994, Journal of virology.

[52]  I. Bernstein,et al.  Inhibition of granulocytic differentiation by mNotch1. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[53]  J. Sklar,et al.  TAN-1, the human homolog of the Drosophila Notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms , 1991, Cell.

[54]  C. Snapper,et al.  Multiple Hemopoietic Defects and Lymphoid Hyperplasia in Mice Lacking the Transcriptional Activation Domain of the c-Rel Protein , 1998, The Journal of experimental medicine.

[55]  G. Weinmaster,et al.  Notch2: a second mammalian Notch gene. , 1992, Development.

[56]  A. Strasser,et al.  Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression. , 1995, Genes & development.

[57]  L. Mazzolini,et al.  A method for the elimination of false positives generated by the mRNA differential display technique. , 1994, BioTechniques.

[58]  P. Meltzer,et al.  Identification and cloning of the human homolog (JAG1) of the rat Jagged1 gene from the Alagille syndrome critical region at 20p12. , 1997, Genomics.

[59]  J. Sklar,et al.  Modulated expression of notch1 during thymocyte development. , 1996, Blood.

[60]  J. Laborda,et al.  T cell leukemia-associated human Notch/translocation-associated Notch homologue has I kappa B-like activity and physically interacts with nuclear factor-kappa B proteins in T cells , 1996, The Journal of experimental medicine.

[61]  J. Hsieh,et al.  Truncated mammalian Notch1 activates CBF1/RBPJk-repressed genes by a mechanism resembling that of Epstein-Barr virus EBNA2 , 1996, Molecular and cellular biology.

[62]  P. Rakic,et al.  Processing of the notch ligand delta by the metalloprotease Kuzbanian. , 1999, Science.

[63]  T. Gridley Notch Signaling in Vertebrate Development and Disease , 1997, Molecular and Cellular Neuroscience.

[64]  Christel Brou,et al.  Signalling downstream of activated mammalian Notch , 1995, Nature.

[65]  T. Enver,et al.  Stromal expression of Jagged 1 promotes colony formation by fetal hematopoietic progenitor cells. , 1998, Blood.